Retrospective evaluation of the Adjuvant! for breast cancer after 5 years of adjuvant tamoxifen (AAT) and other factors for prediction of recurrences (OFPR) following 5 years of adjuvant tamoxifen (AT).
A. Barzi
No relevant relationships to disclose
L. A. Rybicki
No relevant relationships to disclose
B. A. Sisk
No relevant relationships to disclose
C. Yu
No relevant relationships to disclose
M. W. Kattan
No relevant relationships to disclose
G. T. Budd
No relevant relationships to disclose